Cours Cyteir Therapeutics, Inc.
Actions
CYTT
US23284P1030
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Markus Renschler
CEO | Chief Executive Officer | 63 | 01/05/16 |
David Gaiero
DFI | Director of Finance/CFO | 45 | 01/12/20 |
Susan Doleman
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
John Thero
BRD | Director/Board Member | 63 | 04/02/22 |
Markus Renschler
CEO | Chief Executive Officer | 63 | 01/05/16 |
Jean George
BRD | Director/Board Member | 66 | 01/04/13 |
Varia. 1 janv. | Capi. | |
---|---|---|
+1,51 % | 42,59 Md | |
+8,57 % | 40,65 Md | |
+49,22 % | 40,57 Md | |
-12,36 % | 26,77 Md | |
+8,92 % | 24,81 Md | |
-25,13 % | 18,17 Md | |
+29,17 % | 12,05 Md | |
-3,12 % | 11,7 Md | |
+6,35 % | 11,1 Md |